31MAR

Welcome To Mediterr J Med Res

Manuscripts are accepted for consideration with understanding that they are represent original material and they are not being considered for publication elsewhere. The editors welcome the submission of relevant articles for editorial consideration. Manuscripts and all scientific and professional data should be addressed to Editor-in-Cheif (abdulgbaj1@hotmail.com / Fmosherif@yahoo.com).

Mediterranean Journal of Medical Research
https://mrj.org.ly/article/doi/10.5281/zenodo.19074828

Mediterranean Journal of Medical Research

Original article Community medicine

Cancer burden and clinical presentation at Sebha Oncology Centre, Libya: A comparative study of urban and rural patient populations

Mustafa A. Alssageer, Asmaa M. Omar, Mariam W. Ghyte, Eman H. Mohamed

Downloads: 0
Views: 23

Abstract

Cancer represents a growing public health burden in Libya, yet epidemiological data remain limited. The absence of comprehensive cancer registries has resulted in a fragmented understanding of disease patterns and treatment practices. This study aimed to describe the demographic characteristics, clinical presentations, and patterns of chemotherapy utilization among cancer patients attending Sebha Oncology Centre, the sole specialized oncology facility serving southern Libya. A retrospective descriptive study was conducted at Sebha Oncology Centre. Medical records of patients diagnosed and managed between January 2020 and December 2021 were reviewed. Of 309 screened records, 110 met the inclusion criteria and were analyzed. Data extracted included sociodemographic characteristics, cancer type, stage at diagnosis, metastatic status, and treatment modalities. Associations between residence and clinical variables were assessed using Fisher’s Exact Test with effect sizes measured by Cramér’s V. The average age of patients was 51.39 years, with 62.7% aged between 41 and 64 years. Females constituted the majority of the cohort. Breast cancer was the most prevalent malignancy (42.7%), followed by prostate (12.7%) and colorectal cancers (8.2%). Most patients were diagnosed at Stage II (70.9%), and 36.4% presented with metastatic disease. A significant association was found between stage at diagnosis and place of residence, showing that patients from outside Sebha are more likely to present at Stage II. Chemotherapy was the primary treatment modality (80.0%), while surgical and radiotherapy options remained limited. Cancer patients at Sebha Oncology Centre are predominantly middle-aged females, reflecting the high burden of breast cancer. A significant disparity exists in the stage at diagnosis based on geographic residence. The heavy reliance on chemotherapy underscores infrastructure limitations in surgery and radiotherapy. These findings highlight the urgent need for early detection programs, improved oncology infrastructure in Libya, and enhanced healthcare access for rural populations.

Keywords

Cancer epidemiology, clinical presentation, disparity of cancer services, treatment migration

References

  1. Wu Z, Xia F, Lin R. Global burden of cancer and associated risk factors in 204 countries and territories, 1980-2021: A systematic analysis for the GBD 2021. Journal of Hematology and Oncology. 2024; 17(1): 119. doi: 10.1186/s 13045-024-01640-8
  2. Masaud W, Attia A, Abusanoga M, Hasan E. The first comprehensive report of the national cancer registry cancer incidence in Libya 2020; State of Libya, National Cancer Control Program, National Cancer Registry. 2024. Publisher: National Cancer Control Program, Libya. ISBN: 7-3384-1-9959-978.
  3. Azage M, Zewudie S, Goedert MH, Hagos EG. Epidemiological characteristics of cancer patients attending Felege Hiwot Referral Hospital, Northwest Ethiopia. International Journal of Environmental Research and Public Health. 2023; 20(6): 5218. doi: 10.3390/ijerph20065218
  4. Bedwani R, Abdel-Fattah M, El-Shazly M, Bassili A, Zaki A, Seif HA, Weber W. Profile of familial breast cancer in Alexandria, Egypt. Anticancer Research. 2001; 21(4B): 3011-3014. PMID: 11712803.
  5. Benyasaad T, Altrjoman F, Enattah N, Eltaib F, Ashammakhi N, Elzagheid A. Cancer incidence in Western Libya: First results from Tripoli Medical Center. Ibnosina Journal of Medicine and Biomedical Sciences. 2017; 9(02): 37-45. doi: 10.4103/1947-489X.210108
  6. Boder JME, Elmabrouk Abdalla FB, Elfageih MA, Abusaa A, Buhmeida A, Collan Y. Breast cancer patients in Libya: Comparison with European and Central African patients. Oncology Letters. 2011; 2(2): 323-330. doi: 10.3892/ol.2011.245
  7. Calys-Tagoe BNL, Yarney J, Kenu E, Owusu Amanhyia NAK, Enchill E, Obeng I. Profile of cancer patients seen at Korle Bu teaching hospital in Ghana (A cancer registry review). BMC Research Notes. 2014; 7: 577. doi: 10.1186 /1756-0500-7-577
  8. Alhadi AM, Alhadi AM, Mame ME, Mohammed AA, Ali AA. Evaluation of genetic engineering tools in anticancer drug discovery: Evidence-based insights for Libyan Pharmacology Departments. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2025; 5(4): 21-28. doi: 10.5281/zenodo.17334913
  9. Chow CJ, Al-Refaie WB, Abraham A, Markin A, Zhong W, Rothenberger DA, et al. Does patient rurality predict quality colon cancer care?: A population-based study. Diseases of the Colon and Rectum. 2015; 58(4): 415-422. doi: 10.1097/DCR.0000000000000173
  10. Demachi K, Suzuki S, Kamata H, Sugama Y, Ikegawa K, Igarashi T, et al. Impact of outpatient pharmacy services collaborating with oncologists at an outpatient clinic for outpatient chemotherapy prescription orders. European Journal of Oncology Pharmacy. 2019; 2(1): e10. doi: 10.1097/OP9.0000000000000010
  11. Dillekås H, Rogers MS, Straume O. Are 90% of deaths from cancer caused by metastases? Cancer Medicine. 2019; 8(12): 5574-5576. doi: 10.1002/cam4.2474
  12. Douthit N, Kiv T, Dwolatzky T, Biswas S. Exposing some important barriers to health care access in the rural USA. Public Health. 2015; 129(6): 611-620. doi: 10.1016/j.puhe.2015.04.001
  13. El Mistiri M, Verdecchia A, Rashid I, El Sahli N, El Mangush M, Federico M. Cancer incidence in eastern Libya: The first report from the Benghazi Cancer Registry, 2003. International Journal of Cancer. 2007; 120(2): 392-397. doi: 10.1002/ijc.22273
  14. El Ashouri AA, Smeo MNM, Sabei LT, Aldwebi HA, AbuBaker NM, Abu-Khatwa MS, Madi QF. Breast cancer delay presentation among Libyan patients: Demographic and clinical features. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2024; 4(2): 30-36. doi: 10.5281/zenodo.11224367
  15. Extermann M. Measurement and impact of comorbidity in older cancer patients. Critical Reviews in Oncology/ Hematology. 2000; 35(3): 181-200. doi: 10.1016/s1040-8428(00)00090-1
  16. Hudock NL, Mani K, Khunsriraksakul C, Walter V, Nakhlyudov L, Wang M, et al. Future trends in incidence and long-term survival of metastatic cancer in the United States. Communications Medicine. 2023; 3(1): 76. doi. 10.1038/s43856-023-00304-x
  17. Ismail F, Elsayed AG, El-Garawani I, Abdelsameea E. Cancer incidence in the Tobruk area, eastern Libya: First results from Tobruk Medical Centre. Epidemiology and Health. 2021; 43: e2021050. doi: 10.4178/epih.e2021050
  18. Knez L, Laaksonen R, Duggan C. Evaluation of clinical interventions made by pharmacists in chemotherapy preparation. Radiology and Oncology. 2010; 44(4): 249-256. doi: 10.2478/v10019-010-0040-x
  19. Lee L, Cheung, WY, Atkinson E, Krzyzanowska MK. Impact of comorbidity on chemotherapy use and outcomes in solid tumors: A systematic review. Journal of Clinical Oncology. 2011; 29(1): 106-117. doi: 0.1200/JCO.2010. 31.3049
  20. Lu CH, Lee SH, Liu KH, Hung YS, Wang CH, Lin YC, et al. Older age impacts survival outcomes in patients receiving curative surgery for solid cancer. Asian Journal of Surgery. 2018; 41(4): 333-340. doi: 10.1016/j.asjsur. 2017.02.008
  21. Meilleur A, Subramanian SV, Plascak JJ, Fisher JL, Paskett ED, Lamont EB. Rural residence and cancer outcomes in the United States: Issues and challenges. Cancer Epidemiology, Biomarkers and Prevention. 2013; 22(10): 1657-1667. doi: 10.1158/1055-9965.EPI-13-0404
  22. Alssageer MA, Khattab BF, Bakouri AH. Physicians' attitudes, expectations, and experiences about clinical pharmacists and the barriers they face in developing a collaborative relationship with them. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2024; 4(3): 27-38. doi: 10.5281/zenodo.13324209
  23. Elreyani NE, Frewan AI, Abushawashi AM. Medication adherence and clinical outcomes among Libyan patients with chronic diseases: A comparative study of public and private healthcare sectors. Mediterranean Journal of Medical Research. 2025; 2(3): 141-147. doi: 10.5281/zenodo.17127614
  24. De Lauretis F, Sanchez AM, Accetta C, Carnassale B, D’Archi S, Di Leone A, et al. Malignant mesenchymal tumors of the breast: Current challenges and new perspectives on primary sarcomas and malignant phyllodes tumors. Life. 2025; 15(4): 673. doi: 10.3390/life15040673
  25. Satariano WA. The effect of comorbidity on 3-year survival of women with primary breast cancer. Annals of Internal Medicine. 1994; 120(2): 104-110. doi: 10.7326/0003-4819-120-2-199401150-00002
  26. Siddiqui AH, Zafar SN. Global availability of cancer registry data. Journal of Global Oncology. 2018; 4: 1-3. doi: 10.1200/JGO.18.00116
  27. Solomon S, Mulugeta W. Diagnosis and risk factors of advanced cancers in Ethiopia. Journal of Cancer Prevention. 2019; 24(3): 163-172. doi: 0.15430/JCP.2019.24.3.163
  28. Torre, LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends-an update. Cancer Epidemiology, Biomarkers and Prevention. 2016; 25(1): 16-27. doi: 10.1158/1055-9965.EPI-15-0578
  29. Zarmouh A, Almalti A, Alzedam A, Hamad M, Elmughrabi H, Alnajjar L, et al. Cancer incidence in the middle region of Libya: Data from the cancer epidemiology study in Misurata. Cancer Reports. 2022; 5(1): e1448. doi: 10.1002/cnr2.1448

Submitted date:
01/28/2026

Reviewed date:
03/12/2026

Accepted date:
03/17/2026

Publication date:
03/17/2026

69b9b087a95395627639f4a3 mjpe Articles
Links & Downloads

Mediterr J Med Res

Share this page
Page Sections